A new study suggests that the regular use of non-steroidal anti-inflammatory drugs - NSAIDs - may significantly reduce breast cancer risk.  In a recent analysis of more than 80-thousand women between 50 and 79 years of age with no history of cancer, those who regularly used NSAIDs, such as aspirin or ibuprofen for five to nine years reported a 21 percent reduction in the incidence of breast cancer.  Ibuprofen specifically, was found to reduce the risk of breast cancer at a rate that was nearly two times higher than aspirin.  Acetaminophen did not have any effect on breast cancer risk. Leading women's health expert doctor Shari Brasner:

"What's so exciting about this research is that we can tell them that perhaps something that they're already doing, something as simple as taking two Advil tablets a week over the course of years may protect them from breast cancer in the future."

Analyzing data from the National Cancer Institute's Women's Health Initiative Observational Study, researchers noted that even women at high risk for breast cancer may be protected by regular NSAIDs use.

CLICK HERE to download a transcript of this story:
https://www.cpwire.com/click.asp?feature=https://216.86.33.66/candrug.doc

CLICK HERE to download a multimedia (MP3) file of this story:
https://www.cpwire.com/click.asp?feature=https://216.86.33.66/candrug.mp3